120 related articles for article (PubMed ID: 21414629)
21. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
22. Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism.
Bergenfelz A; Lindblom P; Lindergård B; Valdemarsson S; Westerdahl J
World J Surg; 2003 Apr; 27(4):481-5. PubMed ID: 12658497
[TBL] [Abstract][Full Text] [Related]
23. Idiopathic infantile hypercalcemia in children with chronic kidney disease due to kidney hypodysplasia.
Gurevich E; Borovitz Y; Levi S; Perlman S; Landau D
Pediatr Nephrol; 2023 Apr; 38(4):1067-1073. PubMed ID: 36156733
[TBL] [Abstract][Full Text] [Related]
24. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
Watanabe S; Fukumoto S
Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
[TBL] [Abstract][Full Text] [Related]
25. Physiological studies in heterozygous calcium sensing receptor (CaSR) gene-ablated mice confirm that the CaSR regulates calcitonin release in vivo.
Fudge NJ; Kovacs CS
BMC Physiol; 2004 Apr; 4():5. PubMed ID: 15099400
[TBL] [Abstract][Full Text] [Related]
26. Familial hypercalcemia and hypercalciuria: no mutations in the Ca2+-sensing receptor gene.
Rodríguez-Soriano J; Vallo A; Quintela MJ; Pérez de Nanclares G; Bilbao JR; Castaño L
Pediatr Nephrol; 2001 Sep; 16(9):748-51. PubMed ID: 11511994
[TBL] [Abstract][Full Text] [Related]
27. Can biochemical abnormalities predict symptomatology in patients with primary hyperparathyroidism?
Bargren AE; Repplinger D; Chen H; Sippel RS
J Am Coll Surg; 2011 Sep; 213(3):410-4. PubMed ID: 21723154
[TBL] [Abstract][Full Text] [Related]
28. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia.
Fritchie K; Zedek D; Grenache DG
Clin Chim Acta; 2009 Apr; 402(1-2):146-9. PubMed ID: 19168044
[TBL] [Abstract][Full Text] [Related]
29. [Calcium phosphate metabolism in thalassemia].
Praticò G; Di Gregorio F; Caltabiano L; Palano GM; Caruso-Nicoletti M
Pediatr Med Chir; 1998; 20(4):265-8. PubMed ID: 9866849
[TBL] [Abstract][Full Text] [Related]
30. [Familial hypercalcemia and hypophosphatemia: importance in differential diagnosis of disorders in calcium-phosphate metabolism].
Zofková I
Vnitr Lek; 2010 May; 56(5):397-401. PubMed ID: 20578589
[TBL] [Abstract][Full Text] [Related]
31. [Familial hypocalciuric hypercalcemia].
Tóth M; Speer G; Patócs A; Salamon D; Lakatos P; Rácz K; Tulassay Z
Orv Hetil; 2003 Oct; 144(41):2029-31. PubMed ID: 14631896
[TBL] [Abstract][Full Text] [Related]
32. Primary hyperparathyroidism in neonates and childhood. The French experience (1984-2004).
Mallet E;
Horm Res; 2008; 69(3):180-8. PubMed ID: 18219222
[TBL] [Abstract][Full Text] [Related]
33. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
[TBL] [Abstract][Full Text] [Related]
34. Parathyroidectomy: new criteria for evaluating outcome.
Irvin GL; Molinari AS; Carneiro DM; Rivabem F; Ruel MM; Boggs JE
Am Surg; 1999 Dec; 65(12):1186-8; discussion 1188-9. PubMed ID: 10597073
[TBL] [Abstract][Full Text] [Related]
35. Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia.
Shaw JW; Oldham SB; Rosoff L; Bethune JE; Fichman MP
J Clin Invest; 1977 Jan; 59(1):14-21. PubMed ID: 187621
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a laboratory critical limit (alert value) policy for hypercalcemia.
Lum G
Arch Pathol Lab Med; 1996 Jul; 120(7):633-6. PubMed ID: 8757466
[TBL] [Abstract][Full Text] [Related]
37. Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene.
Fencl F; Bláhová K; Schlingmann KP; Konrad M; Seeman T
Eur J Pediatr; 2013 Jan; 172(1):45-9. PubMed ID: 23001465
[TBL] [Abstract][Full Text] [Related]
38. Novel mutations in the calcium-sensing receptor gene associated with biochemical and functional differences in familial hypocalciuric hypercalcaemia.
Ward BK; Magno AL; Blitvich BJ; Rea AJ; Stuckey BG; Walsh JP; Ratajczak T
Clin Endocrinol (Oxf); 2006 May; 64(5):580-7. PubMed ID: 16649980
[TBL] [Abstract][Full Text] [Related]
39. Hypercalcemia due to hypervitaminosis D: report of seven patients.
Joshi R
J Trop Pediatr; 2009 Dec; 55(6):396-8. PubMed ID: 19339514
[TBL] [Abstract][Full Text] [Related]
40. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.
Pearce SH; Trump D; Wooding C; Besser GM; Chew SL; Grant DB; Heath DA; Hughes IA; Paterson CR; Whyte MP
J Clin Invest; 1995 Dec; 96(6):2683-92. PubMed ID: 8675635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
